About
Technology
Issues
FAQ
Links
Official Page
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.